Goodwin Procter advised Advanced Biologics in its merger with Isto Biologics. Isto Biologics, a portfolio company of TSCP and a global leader in regenerative and autologous...
Advanced Biologics’ Merger with Isto Biologics
Novo Nordisk’s $1.3 Billion Acquisition of Ocedurenone
KBP Biosciences was represented by Goodwin Procter LLP and Novo Nordisk was represented by Covington & Burling LLP in this transaction. Novo Nordisk A/S and KBP...